Healthcare Capital Acquisition Corp. I Rights (NASDAQ:HCACR) Sees Significant Growth in Short Interest

Healthcare Capital Acquisition Corp. I Rights (NASDAQ:HCACRGet Free Report) was the recipient of a large increase in short interest in the month of July. As of July 31st, there was short interest totaling 5,197 shares, an increase of 156.8% from the July 15th total of 2,024 shares. Based on an average trading volume of 10,385 shares, the short-interest ratio is presently 0.5 days.

Healthcare Capital Acquisition Corp. I Rights Price Performance

Shares of NASDAQ:HCACR traded down $0.00 during midday trading on Friday, hitting $0.25. The company had a trading volume of 8,019 shares, compared to its average volume of 113,040. Healthcare Capital Acquisition Corp. I Rights has a 12-month low of $0.20 and a 12-month high of $0.35. The business has a fifty day simple moving average of $0.28.

Healthcare Capital Acquisition Corp. I Rights (NASDAQ: HCACR) represent the rights issued in connection with Healthcare Capital Acquisition Corp., a special purpose acquisition company (SPAC) formed to effect a business combination with one or more businesses in the healthcare sector. As a blank-check company, its principal objective is to identify, negotiate and complete an acquisition, merger or similar transaction that will result in a operating public company focused on healthcare-related products and services.

The company’s primary activities are raising capital through its initial public offering and related unit structure, maintaining that capital in trust pending a qualifying business combination, and pursuing potential targets across healthcare subsectors such as pharmaceuticals, biotechnology, medical devices, healthcare services and health technology.

See Also

Receive News & Ratings for Healthcare Capital Acquisition Corp. I Rights Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthcare Capital Acquisition Corp. I Rights and related companies with MarketBeat.com's FREE daily email newsletter.